Zymeworks (ZYME) Receivables (2021 - 2026)

Zymeworks has reported Receivables for 6 years, with the latest figure at $4.7 million in Q1 2026.

• Quarterly Receivables fell 81.0% year-over-year to $4.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.7 million (down 81.0% YoY) and the FY2025 annual result came in at $4.6 million, down 91.69% from the prior year.
• Receivables improved to $4.7 million in Q1 2026 per ZYME's latest filing, from $4.6 million in the prior quarter.
• Over five years, Receivables peaked at $67.3 million in Q3 2023 and troughed at $2.6 million in Q2 2025.
• A 5-year average of $30.1 million and a median of $29.4 million in 2025 frame the typical range for Receivables.
• The sharpest annual moves came in 2023 and 2025: Receivables surged 899.9% in 2023, then plunged 91.8% in 2025.
• Over 5 years, Receivables stood at $33.4 million in 2022, then plunged by 41.69% to $19.5 million in 2023, then surged by 186.57% to $55.8 million in 2024, then plunged by 91.69% to $4.6 million in 2025, then advanced by 0.78% to $4.7 million in 2026.
• According to Business Quant data, Receivables over the past three periods registered $4.7 million, $4.6 million, and $29.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.